Skip to content
NCCPDI_Long
  • About Us
    • Mission & Goals
    • Team
    • Partners
    • FAQs
  • Resources
    • Consulting
    • Pediatric Device Events
    • Media
  • NCC-PDI Competition
  • Projects
  • Contact Us
Menu
  • About Us
    • Mission & Goals
    • Team
    • Partners
    • FAQs
  • Resources
    • Consulting
    • Pediatric Device Events
    • Media
  • NCC-PDI Competition
  • Projects
  • Contact Us
Search
Close

In the News: Brain Cancer Gene Therapy, 2019 Eagles Autism

  • September 21, 2018
Read More...

The University Science Center has selected an innovative gene therapy for brain cancer developed by John M. Maris, MD, pediatric oncologist at CHOP, as one of 12 academic technologies to make the final round of its QED Program, a proof-of-concept life sciences program.

Share on facebook
Facebook
Share on google
Google+
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest
PrevPreviousPelham company named finalist in oediatric innovation
Next11 pediatric cardiovascular devices you need to knowNext
Innovate4Kids

The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) serves as a critical device development resource by providing expert advice, support services, and fund management of pediatric device innovation.

About Us

  • Mission & Goals
  • Team
  • Partners
  • FAQs
  • Privacy Policy

Resources

  • Consulting
  • Pediatric Device Events

Contact Us

NCC-PDI@childrensnational.org

© All rights reserved